Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
HSBC Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $49
HSBC Downgrades Qiagen to Hold
Qiagen Analyst Ratings
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
QIAGEN Reveals Key Updates To Its Sample Technologies Solutions For Non-Invasive Liquid Biopsy Applications
Goldman Sees a 'Relief Rally' Potential for These Option Calls Ahead of Earnings
QIAGEN N.V. to Release Results for Q3 2024 and Hold Webcast
Despite Lower Earnings Than Five Years Ago, Qiagen (NYSE:QGEN) Investors Are up 58% Since Then
Neogen Announces the Appointment of New Board Member
QIAGEN Launches QIAcuityDx Digital PCR System For Clinical Testing In Oncology
Those Who Invested in Qiagen (NYSE:QGEN) Five Years Ago Are up 41%
QIAGEN Receives European IVDR Certification For QIAstat-Dx Syndromic Testing Instruments And Assays
QIAGEN And BD Joint Venture, PreAnalytiX, Launches Solution For Liquid Biopsy From Urine Samples
Qiagen Insiders Sell US$7.0m Of Stock, Possibly Signalling Caution
QIAGEN and Bode Technology Partner to Advance Use of GEDmatch PRO Forensic Genetic Genealogy Database
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $55
BofA Securities analyst Michael Ryskin maintains $Qiagen NV(QGEN.US)$ with a buy rating, and sets the target price at $55.According to TipRanks data, the analyst has a success rate of 57.9% and a
QIAGEN Expands QIAcuity Digital PCR Offering With Over 100 New Assays Via GeneGlobe Platform, Supporting Cancer Research, Genetic Disorders, Infectious Disease Surveillance, And Environmental Monitoring
Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance?
QIAGEN and Bio-Manguinhos/Fiocruz Collaborate to Enhance Malaria and Dengue Detection in Brazil's National Screening Programs